Kyle Rosenke

Dec 5, 2024 | biorxiv.org | Olha Puhach |Eleonore Ostermann |Kyle Rosenke |Laura Staliunaite

AbstractHerpesvirus-based vectors are attractive for use as conventional or transmissible vaccines against emerging zoonoses in inaccessible animal populations. In both cases, cytomegaloviruses as members of the subfamily Betaherpesvirinae are particularly suitable for vaccine development as they are highly specific for their natural host species, infect a large proportion of their host population, and cause mild infections in healthy individuals.